about
Aberrant plasticity of peripheral sensory axons in a painful neuropathyTargeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein.G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence.Cell cycle-coupled expansion of AR activity promotes cancer progression.Sparse conserved under-methylated CpGs are associated with high-order chromatin structureYEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer.TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.Model-based analysis of competing-endogenous pathways (MACPath) in human cancers.Gas41 links histone acetylation to H2A.Z deposition and maintenance of embryonic stem cell identity.BAP1 links metabolic regulation of ferroptosis to tumour suppressionThe ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activationHomeobox oncogene activation by pan-cancer DNA hypermethylationThe ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3.Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients3' UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalkCystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancerHistone H3K23-specific acetylation by MORF is coupled to H3K14 acylationLow-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemiaEnhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance
P50
Q33794063-14AB5CA3-BCDF-4E03-96B7-F7C8E4E19DB4Q33900031-1616732E-6796-4F38-BA3D-E564FDF2BD3FQ36690093-39FECCBC-AEA2-4EF7-AFF9-406CCF8943FAQ38780858-209B1263-EC62-4344-B86A-893CE83B3576Q40565537-199E3B9F-628D-4220-B6BD-86D04452B3CCQ41588474-30FB6CF6-20DA-46C8-AF3F-919B0E9A87C5Q42653067-6A054AB8-3188-4E8A-967D-3BFF1456BB0EQ48371913-E377E871-17DB-4EB2-9D47-A5E6ADC11B14Q52642742-81E88E1E-068A-4ED6-B393-A9AFB0C16CA0Q55100850-68A4BA25-AF9A-49D0-8BEC-D309FBE296A8Q57246269-515E8D3C-3DCB-4190-A9B0-5BF713FA9428Q58740981-A357EE61-2368-4716-A4EC-5230CF1956FEQ58791615-85B830E4-C525-4A7A-BDB6-88F0BF665773Q58886305-7FBBF762-3915-4885-8F74-C064A6F704CFQ64280948-7A57E2C7-E3D2-4DCA-8DF1-48AD725F34A1Q88764847-E0E1A515-C7EB-4149-898F-5322E5EB095BQ90776824-D65430CF-4718-4441-B2EC-246953A61207Q90781875-9B77766D-B4BB-4BA5-9A74-ACE9D96DCE17Q92978962-DAF7F692-298B-4F8E-B3E5-7E10C3DD3374Q95328259-AF7CEC0F-3318-446F-BDB4-C99329A309B4
P50
description
researcher (ORCID 0000-0001-9931-5990)
@en
name
Wei Li
@en
type
label
Wei Li
@en
prefLabel
Wei Li
@en
P31
P496
0000-0001-9931-5990